| Pfizer UK

Cross-Industry Initiative Launches In The Continued Fight Against Antimicrobial Resistance

News & Featured Stories

Antimicrobials Reimbursement Model Pilot

Cross-Industry Initiative Launches In The Continued Fight Against Antimicrobial Resistance

Pfizer announces partnership with NHS England, NICE and UK government in piloting an innovative reimbursement model for antimicrobials, a critical step in tackling the global health threat of antimicrobial resistance (AMR).

What is a Variant?

News & Featured Stories

What is a Variant?

Viruses are constantly changing and evolving as they spread throughout a population; a natural process which can sometimes result in the introduction of new variants. Learn more.

Developing New Medicines

Our Science

Developing New Medicines

Our medicines save and transform the lives of millions around the world every year, but developing them is a complicated process.

Clinical Trials

Our Science

Clinical Trials

Clinical trials are an essential step in the medicine development process

Our Therapy Areas

Our Science

Our Therapy Areas

We focus our efforts in six core areas where we are best positioned to develop unique medicines for much needed therapies.

Pfizer in the UK

Our Science

Pfizer in the UK

Our contribution to the UK spans research and development, supporting education, charitable donations and collaborations with organisations across the healthcare spectrum.